Regional Manual Therapy and Motor Control Exercise for Chronic Low Back Pain
CompletedNot applicableNCT02170753
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Purpose: The primary purpose of this study is to determine whether or not the addition of thoracic, pelvic, and hip manual therapy to a standard physical therapy (PT) approach consisting of motor control exercises and lumbar spine manual therapy is better than standard PT alone at improving thoracolumbar spine range of motion (ROM), hip ROM, pain intensity, disability level, and perceived change in patients with chronic low back pain (CLBP) and movement coordination impairments. Hypothesis: In a CLBP subgroup with movement coordination impairments, participants receiving thoracic, pelvic, and hip manual therapy with standard PT will be superior to participants receiving standard PT alone at improving thoracolumbar spine ROM, hip ROM, pain intensity, physical disability level, and perceived change at two, four, and 12 weeks after initiating treatment.
Study details
- Official title
- Regional Manual Therapy and Motor Control Exercise for the Management of Chronic Low Back Pain With Hip and Spine Motion Loss: A Randomized Clinical Trial
- Conditions
- Interventions
- Procedure: Regional manual therapy
- Procedure: Standard physical therapy
- Sponsor
- University of Texas Southwestern Medical Center
- Collaborators
- Texas Physical Therapy Association
- Start date
- 2014-06
- Primary completion
- 2016-06
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * between the ages of 18 and 65 * have an active complaint of non-specific low back pain for at least three months * demonstrate hypomobility of the thoracic or lumbar regions on at least one spinal level * demonstrate at least two of the following unilateral or bilateral hip ROM deficits: hip flexion \< 110°, hip extension loss \> 6°, or hip rotation \< 30° internally or externally * demonstrate any one of the following: pain that worsens with sustained end- range movements or positions, lumbar hypermobility, diminished trunk or pelvic muscle strength and endurance, or movement coordination impairments during community/work activities * Modified Oswestry Score ≥ 30% Exclusion Criteria: * evidence of red flags, including fracture, infection, spinal tumor, or cauda equina syndrome * pain that can be centralized through repeated movements * signs of hyporeflexia, hypoesthesia, and myotomal weakness indicative of nerve root compression * pregnancy * systemic inflammatory conditions such as rheumatoid arthritis or ankylosing spondylitis * inability to safely tolerate manual therapy to the spine or hips * injections to the low back within the 2 weeks preceding the initial evaluation
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02170753